Turnhout, Belgium

Ludo E Kennis

This inventor holds 42 USPTO granted patents, plus 2 CIPO patents, primarily in Piperidine Derivatives. Top assignees: Janssen Pharmaceutica Nv, Janssen Pharmaceutica. Active years: 1977-2000.


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 12

Forward Citations = 646(Granted Patents)


Location History:

  • Vosselaar, BE (1977 - 1985)
  • Turnhout, BE (1981 - 2000)

Company Filing History:


Years Active: 1977-2000

Loading Chart...
Loading Chart...
Areas of Expertise:
Piperidine Derivatives
Antihypertensive Compounds
Antipsychotic Drugs
Benzisoxazoles
Pyrimidinones
Benzothiazole Derivatives
Piperazine Derivatives
Indazole Derivatives
Quinazoline Compounds
Benzimidazole Derivatives
Thiadiazole Compounds
Amino-Substituted Derivatives
42 patents (USPTO):Explore Patents

Title: The Innovative Mind of Ludo E Kennis

Introduction: Ludo E Kennis, a talented inventor hailing from Turnhout, Belgium, is known for his groundbreaking contributions to the world of inventions and patents.

Latest Patents: Ludo E Kennis has recently been granted patents for his cutting-edge inventions in the fields of renewable energy technology and sustainable agriculture practices.

Career Highlights: Throughout his illustrious career, Ludo E Kennis has been at the forefront of innovation, with a keen focus on developing solutions that address pressing global challenges. His work has garnered recognition for its creativity and practicality.

Collaborations: Ludo E Kennis has collaborated with leading research institutions and universities to further his inventions and bring them to market. His partnerships have been instrumental in advancing his ideas and reaching a wider audience.

Conclusion: In conclusion, Ludo E Kennis stands as a beacon of innovation, constantly pushing the boundaries of what is possible through his inventive spirit and dedication to creating a better world through his inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…